Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete? [electronic resource]
- World journal of gastroenterology Oct 2006
- 6115-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1007-9327
10.3748/wjg.v12.i38.6115 doi
Adenocarcinoma--prevention & control Anti-Inflammatory Agents, Non-Steroidal--pharmacokinetics Colonic Neoplasms--prevention & control Humans Inflammatory Bowel Diseases--drug therapy Mesalamine--pharmacokinetics Sulfasalazine--therapeutic use Treatment Failure Treatment Refusal